// App-Quantinova.ai

949 : Development Of a Comprehensive Rapid Next-Generation Sequencing Assay For The Diagnosis Of Inherited Hemolytic Anemia

Researchers

Presenter

  • Amber Hogart Begtrup

Principal Investigators

  • Neha Dagaonkar

  • Suvarnamala Pushkaran

  • Katie M. Giger

  • Ammar Husami

  • Diane Kissell

  • Clinton H Joiner

  • Mehdi Keddache

  • Kejian Zhang

  • M.B.A

  • Theodosia A. Kalfa

Medical Centers

  • Cancer and Blood Diseases Institute, Cincinnati Childrens Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH

  • Division of Rheumatology, Cincinnati Children's Hospital Medical Center and The University of Cincinnati College of Medicine, Cincinnati, OH

  • Emory University School of Medicine, Atlanta, GA

  • Cancer and Blood Diseases Institute, Cincinnati Childrens Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Blood/haematological Diseases

Disease

  • Hereditary spherocytosis

  • Hereditary pyropoikilocytosis

  • Thalassemia

  • Venous thrombosis

  • Anemia

  • Anemia, congenital dyserythropoietic, 2

Biomarkers

  • Glucose-6-phosphate dehydrogenase

  • Sec23 Homolog B, Coat Complex II Component

  • Red Blood Cells

  • Piezo-type mechanosensitive ion channel component 1

Drug/Treatment

  • CDA-II

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim